Neurogene stops Batten gene therapy after FDA denies request, dealing double dose of bad news Read more 

Incyte's $750M buyout rocked by pause on key trial, asset cull Read more 

Nearing potential FDA approval, BridgeBio shows additional positive data on ATTR-CM candidate acoramidis Read more 

The Royal Society

  1. Events
  2. Organisers
  3. The Royal Society
Events from this organiser
Today

Creating connections in Scotland 2025

This event, hosted at the Technology and Innovation Centre, is designed to gather experts from academia, industry, and government. Its primary purpose is to address [...]

Contractors

Timesheet Portal

Clients
Legal
Contact Us

Copyright © 2025 | Hlx Life Sciences

Site by theLEAP

Go to Top